$CTRN Cashflow Statement | Understand Stock

$CTRN

$45.35 +$0.83 (1.86%) Close

$CTRN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Jan 31, 2026	FY2024 12 months to Feb 1, 2025	FY2023 12 months to Feb 3, 2024
Operating activities:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation
Non-cash operating lease costs
Asset impairment
(Gain) Loss on disposal of property and equipment
Deferred income taxes
Insurance proceeds related to operating activities
Non-cash stock-based compensation expense
Gain on sale of assets or insurance related activities
Gain on sale of assets
Gain on insurance related activities
Changes in assets and liabilities:
Inventory
Prepaid and other current assets
Other assets
Accounts payable
Accrued expenses and other long-term liabilities
Accrued compensation
Income tax payable/receivable
Layaway deposits
Net cash provided by (used in) operating activities
Investing activities:
Purchases of property and equipment
Insurance proceeds related to investing activities
Proceeds from sale of building
Net cash used in investing activities
Financing activities:
Cash used to settle withholding taxes on vested restricted stock
Repurchase of common stock
Net cash used in financing activities
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents:
Beginning of year
End of year
Supplemental disclosures of cash flow information:
Cash paid for interest
Cash (receipts) payments of income taxes
Supplemental disclosures of non-cash investing activities:
Accrual for purchases of property and equipment
Conversion of nonvested cash-settled units to nonvested shares under incentive plan

Comments